Joseph Schwartz Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
53%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
41.7%
Neutral
58.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $70 |
211%
upside
| 1 | +14% |
0
%
| 30 Dec ‘25 18 days ago |
|
|
|
Market Perform
Downgraded
| $14.50 |
1%
upside
| 1 | – |
–
| 29 Dec ‘25 20 days ago |
|
|
|
Market Perform
Downgraded
| $1 |
897%
upside
| 1 | – |
–
| 3 Dec ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $160 |
118%
upside
| 2 | -18% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $14 |
51%
upside
| 1 | +3.8% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Market Perform
Downgraded
| $2 |
100%
upside
| 1 | – |
–
| 3 Dec ‘25 1 month ago |
|
|
|
Market Perform
Downgraded
| $60 |
10%
upside
| 1 | – |
–
| 3 Dec ‘25 1 month ago |
|
|
|
Market Perform
Downgraded
| $16 |
8%
upside
| 1 | – |
–
| 3 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $60 |
163%
upside
| 1 | +43% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $115 |
64%
upside
| 1 | -14% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Market Perform
Downgraded
| $72 |
1%
downside
| 1 | – |
–
| 27 Oct ‘25 2 months ago |
|